Form 4: Senseonics Executive Receives Equity Compensation
Statement of Changes in Beneficial Ownership
Senseonics Holdings, Inc. GC & Corp. Development Advisor Kenneth L. Horton was granted 157,943 RSUs and 217,338 stock options.
Summary
- Kenneth L. Horton, GC & Corp. Development Advisor at Senseonics Holdings, Inc., received a grant of 157,943 restricted stock units (RSUs).
- The reporting person was also granted 217,338 employee stock options with an exercise price of $5.54 per share.
- The RSUs vest in eight equal installments starting June 15, 2026, through subsequent six-month increments.
- The stock options vest in 48 equal monthly installments beginning May 19, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard executive compensation, which does not signal a change in company performance or strategy.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
- Retention mechanism established via multi-year vesting schedules for both RSUs and options.
Negatives
- Potential for future shareholder dilution upon the exercise of options and vesting of RSUs.
Risks
- Continuous service requirements for vesting may lead to executive turnover if employment is terminated.
- Market price volatility could impact the ultimate value of the granted equity.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on executive compensation structure.
Industry Context
StockSavvy.ai notes that equity grants to key management personnel are standard practice in the medical technology sector to ensure leadership retention and incentivize long-term strategic development.
Comparison to Industry Standards
- The use of multi-year vesting schedules (48 months for options) is consistent with standard corporate governance practices for executive compensation in the biotech and medtech industries.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise of these equity instruments.
Next Steps
- Vesting of the first RSU installment on June 15, 2026.
- Ongoing monthly vesting of stock options.
Key Dates
| Date | Description |
|---|---|
| 05/19/2026 | Date of earliest transaction and commencement of vesting for options. |
| 06/15/2026 | First vesting date for RSU grant. |
| 05/21/2026 | Date of filing. |
| 05/18/2036 | Expiration date for the granted stock options. |
Keywords
Senseonics, SENS, Form 4, Insider Transaction, Equity Compensation, Stock Options, RSU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.